Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder
In this cohort study, maternal cannabis use assessed in early pregnancy was not associated with child ASD. Additional studies are needed to evaluate different patterns of use throughout pregnancy. Given the known adverse neonatal health effects of maternal prenatal cannabis use, clinicians should follow national guidelines and advise against use.
Authors
- Lyndsay A. Avalos (ORCID: https://orcid.org/0000-0001-8748-0614)
- Stacey Alexeeff (ORCID: https://orcid.org/0000-0001-8988-6976)
- Lisa Croen (ORCID: https://orcid.org/0000-0001-7849-9428)
- Meghan N. Davignon
- Kelly C. Young‐Wolff (ORCID: https://orcid.org/0000-0002-6177-534X)
- Deborah Ansley (ORCID: https://orcid.org/0000-0002-7806-929X)
- Sara R. Adams (ORCID: https://orcid.org/0009-0005-0896-3199)
- Nina Oberman (ORCID: https://orcid.org/0009-0008-2381-2868)
- Carley Castellanos
- Mahlet Shenkute
Institutions
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- Kaiser Permanente Roseville Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.40301
- Citations
- 10
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 3.43
Funders
- National Institutes of Health
- National Institute on Drug Abuse